New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
201.68+4.60 (+2.33%)
At close: 04:00PM EST
202.88 +1.20 (+0.60%)
After hours: 06:55PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 10.35B
Enterprise value 13.09B
Trailing P/E 21.85
Forward P/E 17.54
PEG ratio (5-yr expected) 1.66
Price/sales (ttm)2.46
Price/book (mrq)3.13
Enterprise value/revenue 3.11
Enterprise value/EBITDA 12.28

Trading information

Stock price history

Beta (5Y monthly) 1.35
52-week change 3-8.38%
S&P500 52-week change 314.23%
52-week high 3262.00
52-week low 3161.65
50-day moving average 3186.85
200-day moving average 3200.28

Share statistics

Avg vol (3-month) 3537.87k
Avg vol (10-day) 3402.09k
Shares outstanding 551.3M
Implied shares outstanding 651.3M
Float 850.71M
% held by insiders 10.98%
% held by institutions 1101.75%
Shares short (14 Nov 2023) 41.63M
Short ratio (14 Nov 2023) 42.45
Short % of float (14 Nov 2023) 43.64%
Short % of shares outstanding (14 Nov 2023) 43.18%
Shares short (prior month 12 Oct 2023) 41.75M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 11.27%
Operating margin (ttm)16.33%

Management effectiveness

Return on assets (ttm)5.51%
Return on equity (ttm)15.96%

Income statement

Revenue (ttm)4.22B
Revenue per share (ttm)82.46
Quarterly revenue growth (yoy)3.80%
Gross profit (ttm)1.46B
EBITDA 972.45M
Net income avi to common (ttm)474.95M
Diluted EPS (ttm)9.24
Quarterly earnings growth (yoy)-9.40%

Balance sheet

Total cash (mrq)157.17M
Total cash per share (mrq)3.06
Total debt (mrq)2.91B
Total debt/equity (mrq)86.77%
Current ratio (mrq)1.45
Book value per share (mrq)64.45

Cash flow statement

Operating cash flow (ttm)697.71M
Levered free cash flow (ttm)340.81M